Ketamine in Pain Management
Sub-Dissociative Dose Ketamine (SDK) in Pain Management 1. Pharmacology & Mechanism of Action Ketamine is an N-methyl-D-aspartate (NMDA) receptor antagonist. In sub-dissociative analgesic doses (0.1–0.3 mg/kg IV), ketamine blocks NMDA-mediated central sensitization, wind-up phenomenon, and hyperalgesia without inducing general anesthesia or procedural dissociation. 2. Dosing Spectrum & Clinical Administration Dosing Category Intravenous Dose Range Primary […]
Ketamine in Pain Management Read More »
